Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer’s disease

Sathe, Gajanan, Na, Chan Hyun, Renuse, Santosh, Madugundu, Anil K., Albert, Marilyn, Moghekar, Abhay, Pandey, Akhilesh·2019·PROTEOMICS – Clinical Applications
DOI 10.1002/prca.201800105

Cited by (127)

Items 101–127 of 127

  1. Analysis of Brain Protein Stability Changes in a Mouse Model of Alzheimer’s Disease
    Yun Tang, Hye-Jin Park, Shengyu Li, Michael C. Fitzgerald · 2024 · Journal of Proteome Research
  2. Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer’s Disease—A Feasibility Study
    Anne Großkopf, Jette Rahn, Ahyoung Kim, Gabor B. Szabo, Dan Rujescu, Frank Klawonn, Andrej Frolov, Andreas Simm · 2024 · Biomedicines
  3. Synapse-associated neuropathological markers in Alzheimer's disease
    Francisco José Barrantes · 2026 · Brain
  4. Cerebrospinal Fluid Protein Profiles in Alzheimer’s Dementia Patients: A Bioinformatic Approach
    Anamika Misra, Sankha Shubhra Chakrabarti, Indrajeet Singh Gambhir, Meghraj Singh Baghel, Yugendra R. Patil · 2023 · Annals of Indian Academy of Neurology
  5. Network Medicine Approach Unravels Endophenotype Signature in Alzheimer’s Disease through Large-Scale Comparative Proteomics Analysis: Vascular Dysfunction as a Prime Example
    Zhao Dai, Xiaocong Pang, Nan Chen, Xiude Fan, Wei Liu, Jinman Liu, Zhuang Chen, Shuhuan Fang, Chuipu Cai, Jiansong Fang · 2024 · Journal of Chemical Information and Modeling
  6. Identifying Sex-Specific Serum Patterns of Alzheimer’s Mice through Deep TMT Profiling and a Concentration-Dependent Concatenation Strategy
    Kaushik Kumar Dey, Jay M. Yarbro, Danting Liu, Xian Han, Zhen Wang, Yun Jiao, Zhiping Wu, Shu Yang, Dong Geun Lee, Abhijit Dasgupta et al. · 2023 · Journal of Proteome Research
  7. Proteomics As A Valid Tool In Biomarker Discovery For Alzheimer's Disease
    Valeria Magnelli · 2024 · Preprints.org
  8. Tau proteoforms as plasma biomarkers in Alzheimer’s disease: mechanisms, measurement, and medicine
    Eunseo Kim, J. H. Lee, DoHyun Han · 2025 · Expert Review of Proteomics
  9. VGF Expression by Monocytes in Patients with Alzheimer’s Disease and Vascular Dementia
    Stefan Busse, Eva Meyer, Henrik Dobrowolny, Christian Mawrin, Roland Hartig, Bernhard Bogerts, Mandy Busse · 2021 · GeroPsych
  10. Bridging Health Disparity Gaps in Alzheimer’s Disease among Marginalized Populations: Clinical Proteomics as a Case Study
    Henry A. Adeola, Renã A. S. Robinson · 2025 · ACS Bio & Med Chem Au
  11. Quantification of the Trans-Synaptic Partners Neuroligin-Neurexin in CSF of Neurodegenerative Diseases by Parallel Reaction Monitoring Mass Spectrometry
    Elena Camporesi, Johanna Nilsson, Agathe Vrillon, Emmanuel Cognat, Claire Hourrègue, Henrik Zetterberg, Kaj Blennow, Bruno Becker, Ann Brinkmalm, Claire Paquet et al. · 2021 · SSRN Electronic Journal
  12. Faculty Opinions recommendation of Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.
    Russell Howard Swerdlow · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  13. Prospective role of PAK6 and 14-3-3γ as biomarkers for Parkinson’s disease
    Laura Civiero, Elena Giusto, Lorenza Maistrello, Lucia Iannotta, Veronica Giusti, Ludovica Iovino, Rina Bandopadhyay, Angelo Antonini, Luigi Bubacco, Rita Barresi et al. · 2023 · Research Square
  14. HSPA8 and 3,4,5-Tricaffeoylquinic Acid May Be Essential Hub Genes and Active Components for the Treatment of Alzheimer's Disease with Erigeron Breviscapus (Vant.) Hand-Mazz by Regulating Ferroptosis: A Study Based on WGCNA, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations
    Bin Xu, Guang Wen Sun, Yundong Zhang · 2024 · SSRN Electronic Journal
  15. Additional file 1 of Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
    Bai, Bing, David Vanderwall, Yuxin Li, Xusheng Wang, Suresh Poudel, Hong Wang, Dey, Kaushik Kumar, Ping‐Chung Chen, Ka Yang, Junmin Peng · 2021 · Figshare
  16. Epigenetic derepression of H3K9me3 mitigates Alzheimer-related pathology and improves cognition via immunomodulation and Vgf induction
    Dieu-Trang S. Fuchs, Jean‐Philippe Vit, Altan Rentsendorj, Julia Sheyn, Haoshen Shi, Yosef Koronyo, Oksana M. Chepurna, Miyah R. Davis, Jered W. Wilson, Lon S. S. Schneider et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Proteomics for Novel Biomarker and Drug Target Discovery in Alzheimer Disease
    Huiming Zhu, Minqi Cai, Dezhu Chen, Jiaojiao Sha, Liang Du, Yiqiang Chen, Siyuan Liu, Qian Zheng, Xuefei Wei, Bing Bai · 2025 · Springer eBooks
  18. The omics techniques used in perineuronal nets research
    Sihan Huang, Jiao Tang, Xiao Ming Wu, Huan Xu, Sihui Li, Hongying Li, Siyu Zhang, Guangxin Xie, Tingyu Wang, Xincheng Pan et al. · 2025 · Experimental Neurology
  19. Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression
    Constance Delaby, Susanna Schraen‐Maschke, Claire Paquet, Frédéric Blanc, Jean‐Sébastien Vidal, Christophe Hirtz, Saïd Assou, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle et al. · 2026 · Molecular Psychiatry
  20. VGF AQEE- and GGEE-peptides differentiate between dementia types
    Barbara Noli, Besnik Muqaku, M. Gouda, AL. Manai, Magdalena Nagl, Sarah Anderl‐Straub, Lucas Werner, Markus Otto, Charlotte Elisabeth Teunissen, Patrick Oeckl et al. · 2025 · Journal of Neurology
  21. Aβ Modulates Extracellular Vesicles Proteomic Profile Impacting Phosphorylation Mediators
    Margarida Vaz, Tânia Soares Martins, Diogo Trigo, Odete A. B. da Cruz e Silva, Francisco Manuel Lemos Amado, Rui Miguel Pinheiro Vitorino, Ana Gabriela Henriques · 2025 · Molecular Neurobiology
  22. H3K9me3 inhibition reverses Alzheimer′s progression by restoring synaptic and immune proteostasis across the brain–retina axis
    Maya Koronyo‐Hamaoui, Dieu-Trang S. Fuchs, Jean‐Philippe Vit, Altan Rentsendorj, Yosef Koronyo, Julia Sheyn, Bhakta Prasad Gaire, Saba Shahin, Haoshen Shi, Oksana M. Chepurna et al. · 2026 · Research Square
  23. Reproducibility-driven discovery and systematic benchmarking reveal a robust cerebrospinal fluid proteomic signature in Alzheimer’s disease
    María Fernanda Zambrano‐Astorga, Aldo Moreno‐Ulloa, the Alzheimer’s Disease Neuroimaging Initiative · 2026 · medRxiv
  24. YWHAG as a novel biomarker in Alzheimer's disease biological research framework
    Qing‐Fei Zhao, Liang-Yu Huang, Yang-Ke Zhu, He‐Ying Hu, Hui-Fu Wang, Wei Zhang, Hao Hu, Lan Tan, Alzheimer’s Disease Neuroimaging Initiative · 2026 · Journal of Alzheimer s Disease
  25. A shared injury–homeostasis gradient in the human CSF proteome across neurological disease
    Alireza Mansouri, Nicholas Mikolajewicz, Cécile Riviere-Cazaux, Kyle J. Tuohy, Sruthi Ranganathan, Rahul Kumar, Alexandra Miller, Manmeet Singh Ahluwalia, Paul Christopher Boutros, Chetan Bettegowda et al. · 2026 · Research Square
  26. Proteomics in health care: recent advances, challenges, and future perspective
    Vinod Rishi, Prakash Bharti, Anjani Kumar · 2026 · Elsevier eBooks
  27. H3K9me3 inhibition reverses Alzheimer's progression by restoring synaptic and immune proteostasis across the brain–retina axis
    D. Fuchs, Jean-Philippe Vit, A. Rentsendorj, Yosef Koronyo, J. Sheyn, B. Gaire, Saba Shahin, Hao-Shen Shi, O. Chepurna, M. R. Davis et al. · 2026 · Alzheimer's & Dementia